nodes	percent_of_prediction	percent_of_DWPC	metapath
Glimepiride—Coma—Methotrexate—psoriatic arthritis	0.00383	0.00383	CcSEcCtD
Glimepiride—Weight increased—Triamcinolone—psoriatic arthritis	0.00363	0.00363	CcSEcCtD
Glimepiride—Weight increased—Methylprednisolone—psoriatic arthritis	0.00362	0.00362	CcSEcCtD
Glimepiride—Bradycardia—Prednisolone—psoriatic arthritis	0.00353	0.00353	CcSEcCtD
Glimepiride—Sweating increased—Dexamethasone—psoriatic arthritis	0.00352	0.00352	CcSEcCtD
Glimepiride—Sweating increased—Betamethasone—psoriatic arthritis	0.00352	0.00352	CcSEcCtD
Glimepiride—Diabetes mellitus—Methotrexate—psoriatic arthritis	0.0035	0.0035	CcSEcCtD
Glimepiride—Sweating—Methylprednisolone—psoriatic arthritis	0.0034	0.0034	CcSEcCtD
Glimepiride—Hepatic failure—Methotrexate—psoriatic arthritis	0.00339	0.00339	CcSEcCtD
Glimepiride—Visual impairment—Prednisolone—psoriatic arthritis	0.00334	0.00334	CcSEcCtD
Glimepiride—Weight increased—Betamethasone—psoriatic arthritis	0.00329	0.00329	CcSEcCtD
Glimepiride—Weight increased—Dexamethasone—psoriatic arthritis	0.00329	0.00329	CcSEcCtD
Glimepiride—Bradycardia—Triamcinolone—psoriatic arthritis	0.00325	0.00325	CcSEcCtD
Glimepiride—Bradycardia—Methylprednisolone—psoriatic arthritis	0.00324	0.00324	CcSEcCtD
Glimepiride—Alanine aminotransferase increased—Prednisone—psoriatic arthritis	0.00321	0.00321	CcSEcCtD
Glimepiride—Abdominal distension—Prednisone—psoriatic arthritis	0.00317	0.00317	CcSEcCtD
Glimepiride—Cerebrovascular accident—Methotrexate—psoriatic arthritis	0.00311	0.00311	CcSEcCtD
Glimepiride—Arrhythmia—Prednisolone—psoriatic arthritis	0.0031	0.0031	CcSEcCtD
Glimepiride—Sweating increased—Prednisone—psoriatic arthritis	0.00307	0.00307	CcSEcCtD
Glimepiride—Visual impairment—Methylprednisolone—psoriatic arthritis	0.00307	0.00307	CcSEcCtD
Glimepiride—Erythema—Prednisolone—psoriatic arthritis	0.00302	0.00302	CcSEcCtD
Glimepiride—Bradycardia—Dexamethasone—psoriatic arthritis	0.00295	0.00295	CcSEcCtD
Glimepiride—Bradycardia—Betamethasone—psoriatic arthritis	0.00295	0.00295	CcSEcCtD
Glimepiride—Weight increased—Prednisone—psoriatic arthritis	0.00287	0.00287	CcSEcCtD
Glimepiride—Arrhythmia—Triamcinolone—psoriatic arthritis	0.00285	0.00285	CcSEcCtD
Glimepiride—Vision blurred—Prednisolone—psoriatic arthritis	0.00285	0.00285	CcSEcCtD
Glimepiride—Arrhythmia—Methylprednisolone—psoriatic arthritis	0.00284	0.00284	CcSEcCtD
Glimepiride—Visual impairment—Betamethasone—psoriatic arthritis	0.00279	0.00279	CcSEcCtD
Glimepiride—Visual impairment—Dexamethasone—psoriatic arthritis	0.00279	0.00279	CcSEcCtD
Glimepiride—Erythema—Triamcinolone—psoriatic arthritis	0.00278	0.00278	CcSEcCtD
Glimepiride—Erythema—Methylprednisolone—psoriatic arthritis	0.00277	0.00277	CcSEcCtD
Glimepiride—Malnutrition—Methylprednisolone—psoriatic arthritis	0.00277	0.00277	CcSEcCtD
Glimepiride—Angioedema—Prednisolone—psoriatic arthritis	0.00276	0.00276	CcSEcCtD
Glimepiride—Loss of consciousness—Prednisolone—psoriatic arthritis	0.00265	0.00265	CcSEcCtD
Glimepiride—Convulsion—Prednisolone—psoriatic arthritis	0.00262	0.00262	CcSEcCtD
Glimepiride—Hypertension—Prednisolone—psoriatic arthritis	0.00261	0.00261	CcSEcCtD
Glimepiride—Eosinophilia—Methotrexate—psoriatic arthritis	0.00261	0.00261	CcSEcCtD
Glimepiride—Arrhythmia—Betamethasone—psoriatic arthritis	0.00259	0.00259	CcSEcCtD
Glimepiride—Arrhythmia—Dexamethasone—psoriatic arthritis	0.00259	0.00259	CcSEcCtD
Glimepiride—Bradycardia—Prednisone—psoriatic arthritis	0.00257	0.00257	CcSEcCtD
Glimepiride—Angioedema—Triamcinolone—psoriatic arthritis	0.00254	0.00254	CcSEcCtD
Glimepiride—Angioedema—Methylprednisolone—psoriatic arthritis	0.00253	0.00253	CcSEcCtD
Glimepiride—Erythema—Betamethasone—psoriatic arthritis	0.00252	0.00252	CcSEcCtD
Glimepiride—Erythema—Dexamethasone—psoriatic arthritis	0.00252	0.00252	CcSEcCtD
Glimepiride—Pancytopenia—Methotrexate—psoriatic arthritis	0.0025	0.0025	CcSEcCtD
Glimepiride—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.00246	0.00246	CcSEcCtD
Glimepiride—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.00244	0.00244	CcSEcCtD
Glimepiride—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.00244	0.00244	CcSEcCtD
Glimepiride—Shock—Prednisolone—psoriatic arthritis	0.00242	0.00242	CcSEcCtD
Glimepiride—Convulsion—Triamcinolone—psoriatic arthritis	0.00241	0.00241	CcSEcCtD
Glimepiride—Tachycardia—Prednisolone—psoriatic arthritis	0.00241	0.00241	CcSEcCtD
Glimepiride—Photosensitivity reaction—Methotrexate—psoriatic arthritis	0.0024	0.0024	CcSEcCtD
Glimepiride—Convulsion—Methylprednisolone—psoriatic arthritis	0.0024	0.0024	CcSEcCtD
Glimepiride—Hypertension—Triamcinolone—psoriatic arthritis	0.0024	0.0024	CcSEcCtD
Glimepiride—Hypertension—Methylprednisolone—psoriatic arthritis	0.00239	0.00239	CcSEcCtD
Glimepiride—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.00238	0.00238	CcSEcCtD
Glimepiride—Anxiety—Methylprednisolone—psoriatic arthritis	0.00235	0.00235	CcSEcCtD
Glimepiride—Drowsiness—Methotrexate—psoriatic arthritis	0.00235	0.00235	CcSEcCtD
Glimepiride—Stevens-Johnson syndrome—Methotrexate—psoriatic arthritis	0.00233	0.00233	CcSEcCtD
Glimepiride—Dry mouth—Triamcinolone—psoriatic arthritis	0.00231	0.00231	CcSEcCtD
Glimepiride—Angioedema—Dexamethasone—psoriatic arthritis	0.0023	0.0023	CcSEcCtD
Glimepiride—Angioedema—Betamethasone—psoriatic arthritis	0.0023	0.0023	CcSEcCtD
Glimepiride—Confusional state—Methylprednisolone—psoriatic arthritis	0.00228	0.00228	CcSEcCtD
Glimepiride—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.00227	0.00227	CcSEcCtD
Glimepiride—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.00226	0.00226	CcSEcCtD
Glimepiride—Arrhythmia—Prednisone—psoriatic arthritis	0.00225	0.00225	CcSEcCtD
Glimepiride—Sweating—Methotrexate—psoriatic arthritis	0.00225	0.00225	CcSEcCtD
Glimepiride—Shock—Triamcinolone—psoriatic arthritis	0.00223	0.00223	CcSEcCtD
Glimepiride—Insomnia—Prednisolone—psoriatic arthritis	0.00223	0.00223	CcSEcCtD
Glimepiride—Shock—Methylprednisolone—psoriatic arthritis	0.00222	0.00222	CcSEcCtD
Glimepiride—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.00221	0.00221	CcSEcCtD
Glimepiride—Loss of consciousness—Betamethasone—psoriatic arthritis	0.00221	0.00221	CcSEcCtD
Glimepiride—Paraesthesia—Prednisolone—psoriatic arthritis	0.00221	0.00221	CcSEcCtD
Glimepiride—Tachycardia—Triamcinolone—psoriatic arthritis	0.00221	0.00221	CcSEcCtD
Glimepiride—Tachycardia—Methylprednisolone—psoriatic arthritis	0.00221	0.00221	CcSEcCtD
Glimepiride—Erythema—Prednisone—psoriatic arthritis	0.00219	0.00219	CcSEcCtD
Glimepiride—Malnutrition—Prednisone—psoriatic arthritis	0.00219	0.00219	CcSEcCtD
Glimepiride—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.00219	0.00219	CcSEcCtD
Glimepiride—Agranulocytosis—Methotrexate—psoriatic arthritis	0.00219	0.00219	CcSEcCtD
Glimepiride—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.00219	0.00219	CcSEcCtD
Glimepiride—Convulsion—Dexamethasone—psoriatic arthritis	0.00218	0.00218	CcSEcCtD
Glimepiride—Convulsion—Betamethasone—psoriatic arthritis	0.00218	0.00218	CcSEcCtD
Glimepiride—Hypertension—Betamethasone—psoriatic arthritis	0.00218	0.00218	CcSEcCtD
Glimepiride—Hypertension—Dexamethasone—psoriatic arthritis	0.00218	0.00218	CcSEcCtD
Glimepiride—Anxiety—Betamethasone—psoriatic arthritis	0.00214	0.00214	CcSEcCtD
Glimepiride—Anxiety—Dexamethasone—psoriatic arthritis	0.00214	0.00214	CcSEcCtD
Glimepiride—Hypotension—Methylprednisolone—psoriatic arthritis	0.00211	0.00211	CcSEcCtD
Glimepiride—Hepatitis—Methotrexate—psoriatic arthritis	0.00211	0.00211	CcSEcCtD
Glimepiride—Vision blurred—Prednisone—psoriatic arthritis	0.00207	0.00207	CcSEcCtD
Glimepiride—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.00206	0.00206	CcSEcCtD
Glimepiride—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.00206	0.00206	CcSEcCtD
Glimepiride—Insomnia—Triamcinolone—psoriatic arthritis	0.00205	0.00205	CcSEcCtD
Glimepiride—Insomnia—Methylprednisolone—psoriatic arthritis	0.00205	0.00205	CcSEcCtD
Glimepiride—Paraesthesia—Triamcinolone—psoriatic arthritis	0.00204	0.00204	CcSEcCtD
Glimepiride—Feeling abnormal—Prednisolone—psoriatic arthritis	0.00203	0.00203	CcSEcCtD
Glimepiride—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.00203	0.00203	CcSEcCtD
Glimepiride—Visual impairment—Methotrexate—psoriatic arthritis	0.00203	0.00203	CcSEcCtD
Glimepiride—Anaemia—Prednisone—psoriatic arthritis	0.00203	0.00203	CcSEcCtD
Glimepiride—Shock—Dexamethasone—psoriatic arthritis	0.00202	0.00202	CcSEcCtD
Glimepiride—Shock—Betamethasone—psoriatic arthritis	0.00202	0.00202	CcSEcCtD
Glimepiride—Dyspnoea—Triamcinolone—psoriatic arthritis	0.00202	0.00202	CcSEcCtD
Glimepiride—Agitation—Prednisone—psoriatic arthritis	0.00202	0.00202	CcSEcCtD
Glimepiride—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.00201	0.00201	CcSEcCtD
Glimepiride—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.00201	0.00201	CcSEcCtD
Glimepiride—Tachycardia—Dexamethasone—psoriatic arthritis	0.00201	0.00201	CcSEcCtD
Glimepiride—Tachycardia—Betamethasone—psoriatic arthritis	0.00201	0.00201	CcSEcCtD
Glimepiride—Angioedema—Prednisone—psoriatic arthritis	0.00201	0.00201	CcSEcCtD
Glimepiride—Dyspepsia—Triamcinolone—psoriatic arthritis	0.002	0.002	CcSEcCtD
Glimepiride—Erythema multiforme—Methotrexate—psoriatic arthritis	0.00199	0.00199	CcSEcCtD
Glimepiride—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.00199	0.00199	CcSEcCtD
Glimepiride—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.00199	0.00199	CcSEcCtD
Glimepiride—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.00199	0.00199	CcSEcCtD
Glimepiride—Anorexia—Betamethasone—psoriatic arthritis	0.00196	0.00196	CcSEcCtD
Glimepiride—Anorexia—Dexamethasone—psoriatic arthritis	0.00196	0.00196	CcSEcCtD
Glimepiride—Urticaria—Prednisolone—psoriatic arthritis	0.00196	0.00196	CcSEcCtD
Glimepiride—Fatigue—Triamcinolone—psoriatic arthritis	0.00195	0.00195	CcSEcCtD
Glimepiride—Fatigue—Methylprednisolone—psoriatic arthritis	0.00195	0.00195	CcSEcCtD
Glimepiride—Loss of consciousness—Prednisone—psoriatic arthritis	0.00193	0.00193	CcSEcCtD
Glimepiride—Hypotension—Dexamethasone—psoriatic arthritis	0.00192	0.00192	CcSEcCtD
Glimepiride—Hypotension—Betamethasone—psoriatic arthritis	0.00192	0.00192	CcSEcCtD
Glimepiride—Convulsion—Prednisone—psoriatic arthritis	0.0019	0.0019	CcSEcCtD
Glimepiride—Hypertension—Prednisone—psoriatic arthritis	0.00189	0.00189	CcSEcCtD
Glimepiride—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.00187	0.00187	CcSEcCtD
Glimepiride—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.00186	0.00186	CcSEcCtD
Glimepiride—Anxiety—Prednisone—psoriatic arthritis	0.00186	0.00186	CcSEcCtD
Glimepiride—Insomnia—Dexamethasone—psoriatic arthritis	0.00186	0.00186	CcSEcCtD
Glimepiride—Insomnia—Betamethasone—psoriatic arthritis	0.00186	0.00186	CcSEcCtD
Glimepiride—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.00185	0.00185	CcSEcCtD
Glimepiride—Paraesthesia—Dexamethasone—psoriatic arthritis	0.00185	0.00185	CcSEcCtD
Glimepiride—Paraesthesia—Betamethasone—psoriatic arthritis	0.00185	0.00185	CcSEcCtD
Glimepiride—Malnutrition—Methotrexate—psoriatic arthritis	0.00183	0.00183	CcSEcCtD
Glimepiride—Erythema—Methotrexate—psoriatic arthritis	0.00183	0.00183	CcSEcCtD
Glimepiride—Hypersensitivity—Prednisolone—psoriatic arthritis	0.00182	0.00182	CcSEcCtD
Glimepiride—Dyspepsia—Betamethasone—psoriatic arthritis	0.00181	0.00181	CcSEcCtD
Glimepiride—Dyspepsia—Dexamethasone—psoriatic arthritis	0.00181	0.00181	CcSEcCtD
Glimepiride—Urticaria—Triamcinolone—psoriatic arthritis	0.0018	0.0018	CcSEcCtD
Glimepiride—Urticaria—Methylprednisolone—psoriatic arthritis	0.0018	0.0018	CcSEcCtD
Glimepiride—Anaphylactic shock—Prednisone—psoriatic arthritis	0.00179	0.00179	CcSEcCtD
Glimepiride—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.00179	0.00179	CcSEcCtD
Glimepiride—Decreased appetite—Betamethasone—psoriatic arthritis	0.00179	0.00179	CcSEcCtD
Glimepiride—Decreased appetite—Dexamethasone—psoriatic arthritis	0.00179	0.00179	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.00178	0.00178	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.00178	0.00178	CcSEcCtD
Glimepiride—Fatigue—Dexamethasone—psoriatic arthritis	0.00177	0.00177	CcSEcCtD
Glimepiride—Fatigue—Betamethasone—psoriatic arthritis	0.00177	0.00177	CcSEcCtD
Glimepiride—Shock—Prednisone—psoriatic arthritis	0.00176	0.00176	CcSEcCtD
Glimepiride—Tachycardia—Prednisone—psoriatic arthritis	0.00175	0.00175	CcSEcCtD
Glimepiride—Hyperhidrosis—Prednisone—psoriatic arthritis	0.00173	0.00173	CcSEcCtD
Glimepiride—Vision blurred—Methotrexate—psoriatic arthritis	0.00173	0.00173	CcSEcCtD
Glimepiride—Anorexia—Prednisone—psoriatic arthritis	0.00171	0.00171	CcSEcCtD
Glimepiride—Anaemia—Methotrexate—psoriatic arthritis	0.0017	0.0017	CcSEcCtD
Glimepiride—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.00169	0.00169	CcSEcCtD
Glimepiride—Feeling abnormal—Betamethasone—psoriatic arthritis	0.00169	0.00169	CcSEcCtD
Glimepiride—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.00168	0.00168	CcSEcCtD
Glimepiride—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.00168	0.00168	CcSEcCtD
Glimepiride—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.00167	0.00167	CcSEcCtD
Glimepiride—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.00167	0.00167	CcSEcCtD
Glimepiride—Leukopenia—Methotrexate—psoriatic arthritis	0.00164	0.00164	CcSEcCtD
Glimepiride—Urticaria—Dexamethasone—psoriatic arthritis	0.00163	0.00163	CcSEcCtD
Glimepiride—Urticaria—Betamethasone—psoriatic arthritis	0.00163	0.00163	CcSEcCtD
Glimepiride—Dizziness—Prednisolone—psoriatic arthritis	0.00163	0.00163	CcSEcCtD
Glimepiride—Asthenia—Triamcinolone—psoriatic arthritis	0.00163	0.00163	CcSEcCtD
Glimepiride—Abdominal pain—Betamethasone—psoriatic arthritis	0.00163	0.00163	CcSEcCtD
Glimepiride—Abdominal pain—Dexamethasone—psoriatic arthritis	0.00163	0.00163	CcSEcCtD
Glimepiride—Asthenia—Methylprednisolone—psoriatic arthritis	0.00162	0.00162	CcSEcCtD
Glimepiride—Insomnia—Prednisone—psoriatic arthritis	0.00162	0.00162	CcSEcCtD
Glimepiride—Paraesthesia—Prednisone—psoriatic arthritis	0.00161	0.00161	CcSEcCtD
Glimepiride—Pruritus—Triamcinolone—psoriatic arthritis	0.0016	0.0016	CcSEcCtD
Glimepiride—Pruritus—Methylprednisolone—psoriatic arthritis	0.0016	0.0016	CcSEcCtD
Glimepiride—Convulsion—Methotrexate—psoriatic arthritis	0.00159	0.00159	CcSEcCtD
Glimepiride—Dyspepsia—Prednisone—psoriatic arthritis	0.00158	0.00158	CcSEcCtD
Glimepiride—Decreased appetite—Prednisone—psoriatic arthritis	0.00156	0.00156	CcSEcCtD
Glimepiride—Rash—Prednisolone—psoriatic arthritis	0.00155	0.00155	CcSEcCtD
Glimepiride—Dermatitis—Prednisolone—psoriatic arthritis	0.00155	0.00155	CcSEcCtD
Glimepiride—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.00155	0.00155	CcSEcCtD
Glimepiride—Fatigue—Prednisone—psoriatic arthritis	0.00154	0.00154	CcSEcCtD
Glimepiride—Headache—Prednisolone—psoriatic arthritis	0.00154	0.00154	CcSEcCtD
Glimepiride—Confusional state—Methotrexate—psoriatic arthritis	0.00151	0.00151	CcSEcCtD
Glimepiride—Dizziness—Triamcinolone—psoriatic arthritis	0.0015	0.0015	CcSEcCtD
Glimepiride—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.0015	0.0015	CcSEcCtD
Glimepiride—Dizziness—Methylprednisolone—psoriatic arthritis	0.0015	0.0015	CcSEcCtD
Glimepiride—Feeling abnormal—Prednisone—psoriatic arthritis	0.00148	0.00148	CcSEcCtD
Glimepiride—Asthenia—Betamethasone—psoriatic arthritis	0.00148	0.00148	CcSEcCtD
Glimepiride—Asthenia—Dexamethasone—psoriatic arthritis	0.00148	0.00148	CcSEcCtD
Glimepiride—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.00147	0.00147	CcSEcCtD
Glimepiride—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.00146	0.00146	CcSEcCtD
Glimepiride—Nausea—Prednisolone—psoriatic arthritis	0.00146	0.00146	CcSEcCtD
Glimepiride—Pruritus—Betamethasone—psoriatic arthritis	0.00145	0.00145	CcSEcCtD
Glimepiride—Pruritus—Dexamethasone—psoriatic arthritis	0.00145	0.00145	CcSEcCtD
Glimepiride—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.00145	0.00145	CcSEcCtD
Glimepiride—Vomiting—Triamcinolone—psoriatic arthritis	0.00144	0.00144	CcSEcCtD
Glimepiride—Vomiting—Methylprednisolone—psoriatic arthritis	0.00144	0.00144	CcSEcCtD
Glimepiride—Rash—Triamcinolone—psoriatic arthritis	0.00143	0.00143	CcSEcCtD
Glimepiride—Dermatitis—Triamcinolone—psoriatic arthritis	0.00143	0.00143	CcSEcCtD
Glimepiride—Anorexia—Methotrexate—psoriatic arthritis	0.00143	0.00143	CcSEcCtD
Glimepiride—Rash—Methylprednisolone—psoriatic arthritis	0.00143	0.00143	CcSEcCtD
Glimepiride—Dermatitis—Methylprednisolone—psoriatic arthritis	0.00142	0.00142	CcSEcCtD
Glimepiride—Urticaria—Prednisone—psoriatic arthritis	0.00142	0.00142	CcSEcCtD
Glimepiride—Headache—Triamcinolone—psoriatic arthritis	0.00142	0.00142	CcSEcCtD
Glimepiride—Headache—Methylprednisolone—psoriatic arthritis	0.00142	0.00142	CcSEcCtD
Glimepiride—Abdominal pain—Prednisone—psoriatic arthritis	0.00142	0.00142	CcSEcCtD
Glimepiride—Diarrhoea—Dexamethasone—psoriatic arthritis	0.00141	0.00141	CcSEcCtD
Glimepiride—Diarrhoea—Betamethasone—psoriatic arthritis	0.00141	0.00141	CcSEcCtD
Glimepiride—Hypotension—Methotrexate—psoriatic arthritis	0.0014	0.0014	CcSEcCtD
Glimepiride—Dizziness—Dexamethasone—psoriatic arthritis	0.00136	0.00136	CcSEcCtD
Glimepiride—Dizziness—Betamethasone—psoriatic arthritis	0.00136	0.00136	CcSEcCtD
Glimepiride—Insomnia—Methotrexate—psoriatic arthritis	0.00135	0.00135	CcSEcCtD
Glimepiride—Nausea—Triamcinolone—psoriatic arthritis	0.00135	0.00135	CcSEcCtD
Glimepiride—Paraesthesia—Methotrexate—psoriatic arthritis	0.00134	0.00134	CcSEcCtD
Glimepiride—Nausea—Methylprednisolone—psoriatic arthritis	0.00134	0.00134	CcSEcCtD
Glimepiride—Dyspnoea—Methotrexate—psoriatic arthritis	0.00133	0.00133	CcSEcCtD
Glimepiride—Somnolence—Methotrexate—psoriatic arthritis	0.00133	0.00133	CcSEcCtD
Glimepiride—Hypersensitivity—Prednisone—psoriatic arthritis	0.00132	0.00132	CcSEcCtD
Glimepiride—Dyspepsia—Methotrexate—psoriatic arthritis	0.00132	0.00132	CcSEcCtD
Glimepiride—Vomiting—Dexamethasone—psoriatic arthritis	0.00131	0.00131	CcSEcCtD
Glimepiride—Vomiting—Betamethasone—psoriatic arthritis	0.00131	0.00131	CcSEcCtD
Glimepiride—Decreased appetite—Methotrexate—psoriatic arthritis	0.0013	0.0013	CcSEcCtD
Glimepiride—Rash—Dexamethasone—psoriatic arthritis	0.0013	0.0013	CcSEcCtD
Glimepiride—Rash—Betamethasone—psoriatic arthritis	0.0013	0.0013	CcSEcCtD
Glimepiride—Dermatitis—Betamethasone—psoriatic arthritis	0.0013	0.0013	CcSEcCtD
Glimepiride—Dermatitis—Dexamethasone—psoriatic arthritis	0.0013	0.0013	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.00129	0.00129	CcSEcCtD
Glimepiride—Fatigue—Methotrexate—psoriatic arthritis	0.00129	0.00129	CcSEcCtD
Glimepiride—Headache—Dexamethasone—psoriatic arthritis	0.00129	0.00129	CcSEcCtD
Glimepiride—Headache—Betamethasone—psoriatic arthritis	0.00129	0.00129	CcSEcCtD
Glimepiride—Asthenia—Prednisone—psoriatic arthritis	0.00128	0.00128	CcSEcCtD
Glimepiride—Pruritus—Prednisone—psoriatic arthritis	0.00127	0.00127	CcSEcCtD
Glimepiride—Feeling abnormal—Methotrexate—psoriatic arthritis	0.00123	0.00123	CcSEcCtD
Glimepiride—Diarrhoea—Prednisone—psoriatic arthritis	0.00123	0.00123	CcSEcCtD
Glimepiride—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.00122	0.00122	CcSEcCtD
Glimepiride—Nausea—Dexamethasone—psoriatic arthritis	0.00122	0.00122	CcSEcCtD
Glimepiride—Nausea—Betamethasone—psoriatic arthritis	0.00122	0.00122	CcSEcCtD
Glimepiride—Urticaria—Methotrexate—psoriatic arthritis	0.00119	0.00119	CcSEcCtD
Glimepiride—Dizziness—Prednisone—psoriatic arthritis	0.00118	0.00118	CcSEcCtD
Glimepiride—Abdominal pain—Methotrexate—psoriatic arthritis	0.00118	0.00118	CcSEcCtD
Glimepiride—Vomiting—Prednisone—psoriatic arthritis	0.00114	0.00114	CcSEcCtD
Glimepiride—Rash—Prednisone—psoriatic arthritis	0.00113	0.00113	CcSEcCtD
Glimepiride—Dermatitis—Prednisone—psoriatic arthritis	0.00113	0.00113	CcSEcCtD
Glimepiride—Headache—Prednisone—psoriatic arthritis	0.00112	0.00112	CcSEcCtD
Glimepiride—Hypersensitivity—Methotrexate—psoriatic arthritis	0.0011	0.0011	CcSEcCtD
Glimepiride—Asthenia—Methotrexate—psoriatic arthritis	0.00107	0.00107	CcSEcCtD
Glimepiride—Nausea—Prednisone—psoriatic arthritis	0.00106	0.00106	CcSEcCtD
Glimepiride—Pruritus—Methotrexate—psoriatic arthritis	0.00106	0.00106	CcSEcCtD
Glimepiride—Diarrhoea—Methotrexate—psoriatic arthritis	0.00102	0.00102	CcSEcCtD
Glimepiride—Dizziness—Methotrexate—psoriatic arthritis	0.00099	0.00099	CcSEcCtD
Glimepiride—Vomiting—Methotrexate—psoriatic arthritis	0.000952	0.000952	CcSEcCtD
Glimepiride—Rash—Methotrexate—psoriatic arthritis	0.000944	0.000944	CcSEcCtD
Glimepiride—Dermatitis—Methotrexate—psoriatic arthritis	0.000943	0.000943	CcSEcCtD
Glimepiride—Headache—Methotrexate—psoriatic arthritis	0.000938	0.000938	CcSEcCtD
Glimepiride—Nausea—Methotrexate—psoriatic arthritis	0.000889	0.000889	CcSEcCtD
